首页> 外文会议>National Conference on Biocybernetics and Biomedical Engineering >In vitro experimental photodynamic diagnosis of artery atherosclerosis
【24h】

In vitro experimental photodynamic diagnosis of artery atherosclerosis

机译:体外实验性光动力学诊断动脉动脉粥样硬化

获取原文

摘要

Background: Although there are several methods for atherosclerosis detection available, none of them seems to be accurate enough to identify the vulnerable atherosclerotic plaque. Photodynamic diagnosis (PDD) and therapy (PDT) - a new method evaluated for neoplasms treatment is a modem approach to detecting and treating atherosclerosis. Aim: The purpose of this study was to asses in vitro the capability of PDD with use of chloirn e6 to recognize atherosclerotic plaque and its usefulness as a feedback system for photoangioplasty treatment. Methods: 30 specimens of human aorta. The samples were soaked with chlorin e6 and then washed out. The luminescence spectra were then collected. All samples were examined with light microscopy. Results: Tissue fluorescence is seen as green light. We noted a very strong red fluorescence of chlorin e6 originating from lipid reach plaque. We established a quantitative factor which would be the ratio R of chlorin e6 red intensity in its 660 nm maximum compared to the area of green luminescence centred at 515 nm. The highest value of the ratio was reached at atheromatous samples, then calcified and normal ones R_2=3.51 +- 0.62, R_3=1.63 +- 0.31, R_1=1.51+- 0.15 respectively . Statistically significant difference was noted between group two and one and between group two and three R_2=3.51 +- 0.62 vs. R_3=1.63 +- 0.31 (p<0,05); R_2=3.51 +- 0.62 vs. R_1=1.51 +- 0.15 (p< 0.05) respectively. Conclusions: The following in vitro study confirms that photosensitizer chlorin e6 accumulates within atheromatous plaque. It may be a specific tool for atheromatous and normal or calcified segments discrimination. The advantage of the above method is a possibility of a real time imaging followed by targeted therapy of various forms and stages of atherosclerosis.
机译:背景:虽然有可用的动脉粥样硬化检测的几种方法,他们都不似乎不够准确识别易损斑块。光动力学诊断(PDD)和治疗(PDT) - 用于肿瘤治疗评价的新方法是一个调制解调器的方法来检测和治疗动脉粥样硬化。目的:本研究的目的是在体外利用chloirn E6的认识到粥样硬化斑块,以及其作为治疗photoangioplasty反馈系统有效性PDD的能力驴。方法:将人主动脉的30个例。将样品用酚e6浸泡,然后冲了出去。然后,将发光光谱收集。所有样品用光学显微镜检查。结果:组织荧光被看作是绿光。我们注意到脂质斑块达到二氢卟酚e6发起的一个非常强的红色荧光。我们建立这将是与在515纳米为中心的绿色发光的面积在其660纳米的最大二氢卟酚的比例R的e6红色强度的定量因素。比的最高值,在动脉粥样化的样品为止,然后钙化和正常的人R_2 = 3.51 + - = 0.62,R_3 1.63 + - 分别为0.15 - 0.31,R_1 = 1.51 +。统计学显著差异在两个基团和一个之间以及两个基团和三个R_2之间注意到= 3.51 + - 0.62对比R_3 = 1.63 + - 0.31(P <0.05); R_2 = 3.51 + - 0.62对比R_1 = 1.51 + - 0.15分别(P <0.05)。结论:在体外研究证实,光敏剂二氢卟酚e6积聚粥样硬化斑块内的以下。它可以是用于动脉粥样硬化和正常或钙化段判别的特定工具。上述方法的优点是一个实时成像,随后的各种形式和动脉粥样硬化的阶段靶向治疗的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号